Discover expert tips from an obesity medicine doctor on effective and sustainable ways to approach weight loss for type 2 ...

Navi Mumbai: A state-of-the-art Institute of Clinical Obesity and Metabolism to be inaugurated on Saturday at Apollo Hospital ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

These presentations will be accessible on the Events section of the Altimmune website.

The U.S. military has lessened its stringent health requirements to cope with lagging recruitment numbers, contributing to an ...

The Health Ministry has reported that 50 percent of women and 25 percent of men in Indonesia have central or abdominal ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

(The Center Square) - Sen. Ruben Gallego, D-Arizona, announced his support for a bill aimed at helping America’s obesity ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Adolescents face significant barriers to obesity medication access, despite a surge in prescriptions. Discover the ...

A newly discovered mechanism that leads to liver dysfunction may be a key factor in type 2 diabetes and other metabolic ...

A large European study found that consuming a greater variety of plant-based proteins, vegetables, and major food groups is linked to a lower risk of developing type 2 diabetes. The protective effect ...